DEFAZIO, GIOVANNI
 Distribuzione geografica
Continente #
EU - Europa 174.316
NA - Nord America 16.025
AS - Asia 7.818
SA - Sud America 1.972
AF - Africa 222
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 3
Totale 200.382
Nazione #
IT - Italia 171.039
US - Stati Uniti d'America 15.631
SG - Singapore 3.218
CN - Cina 2.166
BR - Brasile 1.546
VN - Vietnam 958
SE - Svezia 668
FR - Francia 426
UA - Ucraina 410
DE - Germania 405
FI - Finlandia 363
GB - Regno Unito 353
HK - Hong Kong 311
CA - Canada 227
IN - India 195
AR - Argentina 167
BD - Bangladesh 166
NL - Olanda 166
TR - Turchia 123
KR - Corea 97
MX - Messico 91
JP - Giappone 80
EC - Ecuador 76
IQ - Iraq 70
ID - Indonesia 69
RU - Federazione Russa 68
AT - Austria 66
ZA - Sudafrica 62
ES - Italia 59
CO - Colombia 52
PK - Pakistan 45
PL - Polonia 45
PH - Filippine 40
MA - Marocco 36
SA - Arabia Saudita 36
VE - Venezuela 32
CH - Svizzera 31
CL - Cile 30
IE - Irlanda 30
UZ - Uzbekistan 28
EG - Egitto 27
IR - Iran 27
PY - Paraguay 27
RO - Romania 27
AE - Emirati Arabi Uniti 22
PE - Perù 22
BE - Belgio 21
JM - Giamaica 21
KE - Kenya 21
CZ - Repubblica Ceca 20
IL - Israele 20
MY - Malesia 20
AL - Albania 17
TN - Tunisia 17
NP - Nepal 16
TW - Taiwan 16
AU - Australia 15
GR - Grecia 14
JO - Giordania 13
DO - Repubblica Dominicana 12
DZ - Algeria 12
AZ - Azerbaigian 11
BG - Bulgaria 11
NZ - Nuova Zelanda 11
PT - Portogallo 11
KZ - Kazakistan 10
RS - Serbia 10
CR - Costa Rica 9
ET - Etiopia 9
LT - Lituania 9
UY - Uruguay 9
BO - Bolivia 8
PA - Panama 8
PS - Palestinian Territory 8
LB - Libano 7
NG - Nigeria 7
OM - Oman 7
TH - Thailandia 7
GH - Ghana 6
HN - Honduras 6
HU - Ungheria 6
KG - Kirghizistan 6
MG - Madagascar 6
DK - Danimarca 5
HR - Croazia 5
LV - Lettonia 5
QA - Qatar 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BH - Bahrain 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
EE - Estonia 4
GT - Guatemala 4
KH - Cambogia 4
SY - Repubblica araba siriana 4
MU - Mauritius 3
SN - Senegal 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
Totale 200.338
Città #
Cagliari 160.657
Uta 5.671
Fairfield 2.299
Ashburn 1.525
Singapore 1.278
Woodbridge 982
Seattle 896
Boardman 839
Houston 819
Dallas 764
San Jose 762
Wilmington 751
Cambridge 740
Nyköping 495
Ann Arbor 444
Beijing 426
Milan 409
Rome 395
Helsinki 337
Chandler 322
Ho Chi Minh City 320
The Dalles 312
Los Angeles 305
Hong Kong 268
Lauterbourg 237
New York 236
Shanghai 224
Hanoi 218
Boston 217
Jacksonville 212
Nanjing 165
Buffalo 157
Santa Clara 154
São Paulo 148
Guangzhou 147
Council Bluffs 141
Munich 125
San Diego 124
Toronto 122
Dearborn 111
Naples 106
Turin 85
London 81
Bologna 79
Redwood City 79
Catania 74
Florence 66
Millbury 63
Bari 61
Shenyang 59
Norwalk 58
Tianjin 57
Trabzon 56
Seoul 54
Augusta 53
Changsha 53
Dong Ket 52
Hefei 52
Chicago 51
Nuremberg 49
Frankfurt am Main 48
Rio de Janeiro 45
Tokyo 45
Verona 44
Orem 43
Palermo 41
Haiphong 40
Jiaxing 40
Da Nang 39
Hebei 39
Nanchang 37
Redondo Beach 37
Atlanta 32
Curitiba 32
Padova 32
Vienna 32
Genoa 31
San Mateo 31
Brasília 30
Chennai 30
Wuhan 30
Guayaquil 29
Montreal 29
Phoenix 29
Belo Horizonte 28
Brescia 27
Mountain View 26
Mexico City 25
Sassari 25
Tashkent 25
Brooklyn 24
Shenzhen 24
Baghdad 23
Biên Hòa 23
Denver 23
Düsseldorf 23
Parma 23
Hải Dương 22
Mumbai 22
Pescara 22
Totale 187.292
Nome #
Efficacy and safety of the 5-Hydroxytryptophan on Levodopa-Induced Motor Complications in Parkinson's disease 24.356
Effect of olfactory and gustatory dysfunction and motor symptoms on body weight in patients with Parkinson’s disease 4.470
Neurosifilide e stroke ischemico: case report. 3.865
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Parkinson's disease: a preliminary finding 3.346
Olfactory function and apathy as potential biomarker in patients with Parkinson's disease 3.035
Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial 2.752
Epilessia mioclonica progressiva o epilessia parziale continua? 2.519
Gender differences in olfactory function in patients with Parkinson's disease. 2.470
Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson's disease 2.374
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.368
Correlation among olfactory function, motors’ symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson’s disease 2.332
Sleep cardiac dysautonomia and EEG oscillations in Amyotrophic Lateral Sclerosis 2.274
Efficacy and Safety of the 5-Hydroxytryptophan on REM Sleep Behavior Disorder in Parkinson's Disease 2.269
Severity of REM sleep without atonia (RSWA) correlates with cognitive functions in patients with REM sleep behaviour disorder (RBD) 2.201
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Idiopathic Parkinson's disease 2.166
Neuropsychological and behavioral profile of patients with isolated REM sleep behaviour disorders (iRBD) and patients with RBD associated with Parkinson's Disease (PDRBD) 2.129
Gender differences in olfactory dysfunctions in Sardinian patients affected by Parkinson’s disease 2.122
CORRELATION AMONG OLFACTORY DYSFUNCTION, APATHY AND FATIGUE IN PATIENTS WITH PARKINSON’S DISEASE 2.087
Upper limb movements in dementia with Lewy body: a quantitative analysis 1.974
Sensory trick in upper limb dystonia 1.968
Pulvinar sign in a case of anti-CV2 encephalitis 1.908
A “Catastrophic” Heparin-Induced Thrombocytopenia 1.890
Association between dopaminergic medications and REM sleep behavior disorder in Parkinson’s disease: a preliminary cohort study 1.759
NCSE: un caso di steroid-responsive encephalopathy associated with autoimmune thyroiditis 1.733
Genetic Creutzfeldt-Jakob disease in Sardinia: a case series linked to the PRNP R208H mutation due to a single founder effect 1.677
Prevalence of Huntington's disease in Southern Sardinia, Italy 1.650
Geographic differences in the incidence of Huntington's disease in Sardinia, Italy 1.597
Internal carotid artery dissection causing ischemic stroke during pole sport practice 1.560
Expert recommendations for diagnosing cervical, oromandibular, and limb dystonia 1.560
Impact of supporting people with advanced Parkinson’s disease on carer’s quality of life and burden 1.553
Carotid plaque imaging profiling in subjects with risk factors (diabetes and hypertension) 1.532
Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study 1.427
The Relationships Between Ataxia and Cognition in Spinocerebellar Ataxia Type 2 1.411
Does acute peripheral trauma contribute to idiopathic adult-onset dystonia? 1.298
Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia 1.278
Cerebellar Syndrome Associated with Thyroid Disorders 1.225
Does the network model fits neurophysiological abnormalities in blepharospasm? 1.222
Serum anti-thyroid antibodies in Hashimoto’s encephalopathy: A never-ending story 1.222
Idiopathic Non-Task-Specific Upper Limb Dystonia, a Neglected Form of Dystonia 1.190
Demographic and clinical determinants of neck pain in idiopathic cervical dystonia 1.175
Cannabinoids and dystonia: an issue yet to be defined 1.164
Advances in the pathophysiology of adult-onset focal dystonias: recent neurophysiological and neuroimaging evidence. 1.151
Functional neurological disorder after COVID-19 vaccination 1.095
Movement disorders phenomenology in focal motor seizures 1.083
Cognitive and Behavioral features of isolated Rem Sleep Bhaviour disorders (IRBD) and RBD associated with Parkinson's disease (PDRBD 1.050
Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest? 1.020
The role of sensory information in the pathophysiology of focal dystonias 964
Neurophysiological features of REM sleep Behaviour Disorder (RBD) correlate with cognitive and psycho-behavioral profile 963
Status epilepticus in Hashimoto's encephalopathy 951
Role of dopaminergic neurotransmission in pathophysiology of action tremor in Parkinson's disease 950
Effects of White Matter Hyperintensities on Brain Connectivity and Hippocampal Volume in Healthy Subjects According to Their Localization 950
Therapeutic Use of Cerebellar Intermittent Theta Burst Stimulation (iTBS) in a Sardinian Family Affected by Spinocerebellar Ataxia 38 (SCA 38) 950
Qualitative smell/taste disorders as sequelae of acute COVID-19 899
Persistent myoclonic jerks: a case of epilepsia partialis continua or myoclonic progressive epilepsy? 897
Diagnostic criteria for blepharospasm: A multicenter international study 885
Development of a Clinical Rating Scale for the Severity of Apraxia of Eyelid Opening, Either Isolated or Associated with Blepharospasm 881
Reshaping cortical connectivity in traumatic spinal cord injury: a novel effect of hyperbaric oxygen therapy 881
Effetti della stimolazione del nervo vago sulle componenti aperiodiche dell’EEG in soggetti affetti da epilessia resistente ai farmaci 867
Frequency and Determinants of Olfactory Hallucinations in Parkinson’s Disease Patients 867
Disease progression in blepharospasm: a 5-year longitudinal study 862
Risk factors of Parkinson disease. Simultaneous assessment, interactions, and etiologic subtypes 858
Olfactory impairment in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype: a pilot study 844
Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease 837
Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease 801
Does Olfactory Dysfunction Correlate with Disease Progression in Parkinson’s Disease? A Systematic Review of the Current Literature 799
Is Adult-Onset Dystonia a Rare Disease? Time for Population-Based Studies 767
23. Effects of vagal nerve stimulation on EEG aperiodic parameters in subjects affected by drug-resistant epilepsy 756
Validation of a guideline to reduce variability in diagnosing cervical dystonia 754
Rasagiline withdrawal Syndrome in Parkinson’s Disease 754
Pain in Parkinson's disease: facts and uncertainties 751
Olfactory Impairment Correlates with Executive Functions Disorders and Other Specific Cognitive Dysfunctions in Parkinson’s Disease 740
Neuroimaging in idiopathic adult-onset focal dystonia 728
Incidence of amyotrophic lateral sclerosis in Sardinia, Italy: age-sex interaction and spatial-temporal variability 709
Neurological phenomenology of the IRF2BPL mutation syndrome: Analysis of a new case and systematic review of the literature 703
Whole-exome sequencing for variant discovery in blepharospasm 685
Pain in focal dystonias - A focused review to address an important component of the disease 683
Global Fractional Anisotropy: Effect on Resting-state Neural Activity and Brain Networking in Healthy Participants 683
The Pathophysiological Correlates of Parkinson's Disease Clinical Subtypes 679
Early juvenile reading epilepsy and later frontotemporal dementia (FTD): expanding the clinical phenotype of C9ORF72 mutation? 679
Estimated EEG functional connectivity and aperiodic component induced by vagal nerve stimulation in patients with drug-resistant epilepsy 673
The mid-term effects of carotid endarterectomy on cognition and regional neural activity analyzed with the amplitude of low frequency fluctuations technique 669
Functional gait disorders: Demographic and clinical correlations 652
Association between olfactory dysfunction and motor subtypes in Parkinson’s disease: are non‑tremor‑dominant subtypes really uncorrelated to olfactory impairment? 647
Incidence and spatial distribution of adult-onset primary malignant and other central nervous system tumors in Southern Sardinia, Italy 645
Olfactory hallucinations in Parkinson’s disease patients and the role of their evaluation in clinical practice. 644
Motor and non-motor symptoms in blepharospasm: clinical and pathophysiological implications 629
Functional neurological disorders as seen by a cohort of general practitioners in northern italy: Evidence from an online survey 621
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson's disease 617
Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site 597
A neural network-based software to recognise blepharospasm symptoms and to measure eye closure time 583
Severity of REM sleep without atonia correlates with measures of cognitive impairment and depressive symptoms in REM sleep behaviour disorder 580
Effect of botulinum toxin on non-motor symptoms in cervical dystonia 578
Does epilepsy contribute to the clinical phenotype of C9orf72 mutation in fronto-temporal dementia? 574
The Italian Dystonia Registry: rationale, design and preliminary findings 572
Involuntary Thumb Flexion on Neurological Examination: An Unusual Form of Upper Limb Dystonia in the Faroe Islands 572
Cocaine-induced Pisa syndrome 565
Smoking and age-at-onset of both motor and non-motor symptoms in Parkinson's disease 564
Blepharospasm 40 years later 553
The association between white matter hyperintensities, cognition and regional neural activity in healthy subjects 547
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study 538
Totale 149.104
Categoria #
all - tutte 315.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 315.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.384 0 0 0 0 0 0 0 0 0 0 0 1.384
2021/202212.196 1.218 995 635 760 965 868 971 740 935 1.142 1.380 1.587
2022/202319.487 1.818 2.317 2.138 1.480 1.437 1.602 1.085 2.652 1.165 1.314 1.526 953
2023/202424.834 1.193 887 1.093 2.027 2.360 3.609 3.982 1.713 1.167 1.787 2.601 2.415
2024/202563.468 16.411 11.939 13.929 7.507 3.000 3.611 4.093 267 838 910 403 560
2025/202613.588 1.145 432 1.860 1.911 915 921 2.311 625 1.038 1.317 639 474
Totale 201.489